Vaginal progesterone
Vaginal progesterone is a pharmaceutical drug with 29 clinical trials. Currently 2 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
12 of 16 finished
25.0%
4 ended early
2
trials recruiting
29
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor
A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
Effectiveness of Targeted Cervical Length Screening Guided by a Preterm Birth Risk Scoring System in Reducing the Rate of Preterm Birth
Cerclage With Progesterone Versus Progesterone Only in Singleton Pregnancies
Clinical Trials (29)
A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor
A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
Effectiveness of Targeted Cervical Length Screening Guided by a Preterm Birth Risk Scoring System in Reducing the Rate of Preterm Birth
Cerclage With Progesterone Versus Progesterone Only in Singleton Pregnancies
Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles
Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix
Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
Pessary Versus Cerclage With or Without Progesterone in Twins
Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age Fetuses
Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support
Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support
Comparing IM vs. Vaginal Progesterone for Pre-term Birth
Pessary Versus Progesterone in Singletons
Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth
Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa
Effect of Cervical Cerclage With Vaginal Progesterone in Asymptomatic Twin Pregnancies With a Sonographic Short Cervix
Progesterone in Patients With Placenta Previa
Different Types of Progesterone in the Prevention of Preterm Labor
Cerclage for Twins With Short Cervix
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 29